Wednesday, February 10, 2010, 4:49pm SGT - The Singapore stock market closes in 11 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEFINANCE NEWS
    Market:       |  

TranS1, Inc. (TSON)

At 5:00AM SGT: 3.14 USD   0.00 (0.00%)  
 MORE ON TSON 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 TranS1 Inc. (NGM:TSON) Delayed quote dataEdit
Last Trade:3.14 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:3.14
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:8.00
Day's Range:N/A - N/A
52wk Range:3.01 - 8.74
Volume:0
Avg Vol (3m):38,720.6
Market Cap:64.79M
P/E (ttm):N/A
EPS (ttm):-1.07
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
 Add TSON to Portfolio   Download Data

 HEADLINES 
TRANS1 INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Sat, Jan 23)
Cashing In on Obamacare
at Motley Fool (Fri, Jan 22)
TRANS1 INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Wed, Jan 13)
TranS1 Reports Preliminary Revenues
Zacks.com (Sat, Jan 9)
TranS1 Inc. to Present at the J.P. Morgan Healthcare Conference
GlobeNewswire (Fri, Jan 8)
TranS1 Inc. Announces Preliminary Revenue Results for Fourth Quarter
GlobeNewswire (Fri, Jan 8)
TranS1 Inc. Partners With Life Spine, Inc. to Distribute Avatar(TM), a New Minimally Invasive Pedicle Screw System
GlobeNewswire (Fri, Jan 8)
TranS1 Inc. Announces Appointment of Ken Reali as President and Chief Operating Officer
GlobeNewswire (Fri, Jan 8)
TranS1 Inc. to Present at the Piper Jaffray Health Care Conference
GlobeNewswire (Wed, Dec 2)
TRANS1 INC Financials
EDGAR Online Financials (Wed, Nov 11)
TRANS1 INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Sat, Nov 7)
More Headlines for TSON...

 ANALYST 
EPS Est (next year) (Dec-09) :-1.19
EPS Est (in 2 years) (Dec-10) :-1.03
Avg Rec (current)*:2.6
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
TranS1 Inc., a medical device company, focuses on the design, development, and marketing of products that implement its proprietary surgical approach to treat degenerative disc disease and instability affecting the lower lumbar region of the spine.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
Latest NewsSingapore Indices